HLB Co., Ltd. (KOSDAQ:028300)
51,800
-100 (-0.19%)
At close: Feb 27, 2026
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 6.88 trillion as of February 27, 2026. Its market cap has decreased by -34.07% in one year.
Market Cap
6.88T
Enterprise Value
7.08T
Revenue
80.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,800.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 6.88T, an increase of 51,032.91%. That is a compound annual growth rate of 43.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 6.88T | 2.95% |
| Dec 30, 2025 | 6.69T | -30.26% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 21.79T |
| SK Biopharmaceuticals | 9.38T |
| LigaChem Biosciences | 6.98T |
| Peptron | 6.68T |
| Voronoi | 6.02T |
| SK bioscience | 3.91T |
| D&D Pharmatech | 3.87T |
| PharmaResearch | 3.63T |